Search Results for: tuberculosis
While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution.    Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading ->
The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use  in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading ->
Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met.  In a separate letter signed by 37 […] Continue reading ->

Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227
In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading ->
US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch.  There are some 23,000 GeneXpert […] Continue reading ->
As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading ->
While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading ->
World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading ->
Contact Us
info@healthpolicy-watch.org
1-5 Route des Morillions CP 2100
Geneva 1211, Switzerland
+41 22 791 67 28
About
Privacy Policy
Archives
Staff Access
Log in
Entries RSS
Comments RSS
Wordpress.org
Supported by
Copyright c 2020 Global Policy Reporting